Effects of postmenopausal hormone replacement therapy on body fat composition

Gynecological Endocrinology

Volumn 23, Issue 2, 2007, Pages 99-104

  Yüksel, Hasan ^a   Odabaşi, Ali Riza ^a   Demircan, Selda ^a   Köseoǧlu, Kutsi ^a   Kizilkaya, Kadir ^a   Onur, Ergün ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Body composition; Estradiol; Medroxyprogesterone acetate; Menopause; Norethisterone acetate; Subcutaneous fat

Indexed keywords

ESTRADIOL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEIGHT; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; ULTRASOUND; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ABDOMINAL FAT; ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; BODY FAT DISTRIBUTION; BODY WEIGHT; CARDIOVASCULAR DISEASES; DRUG COMBINATIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; NORETHINDRONE; RISK FACTORS; WAIST-HIP RATIO;

EID: 33947593532     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590601152177     Document Type: Article

References (25)

1. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Am Med Assoc 1995;273:199-208.
2. Gambacciani M, Ciaponi M, Cappagli B, De Simone L, Orlandi R, Genazzani AR. Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy. Maturitas 2001;39:125-132.
3. Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric 2004;7:375-389.
4. World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation on obesity, WHO/NUT/NCD. Geneva: WHO; 1998.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001;285:2486-2497.
6. Seidell JC, Kahn HS, Williamson DF, Lissner L, Valdez R. Report from a Centers for Disease Control and Prevention Workshop on use of adult anthropometry for public health and primary health care. Am J Clin Nutr 2001;73:123-126.
7. Terry RB, Page WF, Haskell WL. Waist/hip ratio, body mass index and premature cardiovascular disease mortality in US army veterans during a twenty-three year follow-up study. Int J Obes Relat Metab Disord 1992;16:417-423.
8. Onat A, Sansoy V, Uysal O. Waist circumference and waist-to-hip ratio in Turkish adults: interrelation with other risk factors and association with cardiovascular disease. Int J Cardiol 1999;70:43-50.
9. Norman RJ, Flight IH, Rees MC. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and postmenopausal women: weight and body fat distribution. Cochrane Database Syst Rev 2000;2:CD001018.
10. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-333.
11. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obes Res 1998;6(Suppl 2):51-209.
12. Yano K, Hosokawa K, Nakai K, Kubo T, Matsuo Y. Regional differences in ultrasonic assessment of subcutaneous fat thickness in the abdomen: effects on the TRAM flap. Ann Plast Surg 2003;51:130-135.
13. Kristensen K, Pedersen SB, Vestergaard P, Mosekilde L, Richelsen B. Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women. J Endocrinol 1999;163:55-62.
14. Elbers JM, de Roo GW, Popp-Snijders C, Nicolaas-Merkus A, Westerveen E, Joenje BW, Netelenbos JC. Effects of administration of 17β-oestradiol on serum leptin levels in healthy postmenopausal women. Clin Endocrinol (Oxf) 1999;51:449-454.
15. Di Carlo C, Tommaselli GA, Pisano G, Nasti A, Rossi V, Palomba S, Nappi C. Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy. Menopause 2000;7:36-41.
16. Gower BA, Nagy TR, Goran MI, Smith A, Kent E. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution. J Clin Endocrinol Metab 2000;85:770-775.
17. Salbach B, Nawroth PP, Kubler W, von Holst T, Salbach PB. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy. Eur J Med Res 2000;5:63-66.
18. O'Sullivan AJ, Crampton LJ, Freund J, Ho KK. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J Clin Invest 1998;102:1035-1040.
19. Perrone G, Liu Y, Capri O, Critelli C, Barillaro F, Galoppi P, Zichella L. Evaluation of the body composition and fat distribution in long-term users of hormone replacement therapy. Gynecol Obstet Invest 1999;48:52-55.
20. Di Carlo C, Tommaselli GA, Sammartino A, Bifulco G, Nasti A, Nappi C. Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy. Menopause 2004;11:466-473.
21. Laivuori H, Koistinen HA, Karonen SL, Cacciatore B, Ylikorkala O. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women. Hum Reprod 2001;16:1632-1635.
22. Walker RJ, Lewis-Barned NJ, Sutherland WH, Goulding A, Edwards EA, de Jong SA, Gold E, Walker HL. The effects of sequential combined oral 17β-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study. Menopause 2001;8:27-32.
23. Arabi A, Garnero P, Porcher R, Pelissier C, Benhamou CL, Roux C. Changes in body composition during postmenopausal hormone therapy: a 2 year prospective study. Hum Reprod 2003;18:1747-1752.
24. Zhu S, Heshka S, Wang Z, Shen W, Allison DB, Ross R, Shen W, Allison DB, Ross R, Heymsfield SB. Combination of BMI and waist circumference for identifying cardiovascular risk factors in whites. Obes Res 2004;12:633-645.
25. Despres JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. Br Med J 2001;322:716-720.